openPR Logo
Press release

Next Generation Sequencing (NGS) Market Analysis by key players Thermo Fisher Scientific Inc., Illumina, Inc., Roche Holding AG QIAGEN N. V., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., GA

06-07-2019 07:28 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: marketstudyreport

/ PR Agency: marketstudyreport
Next Generation Sequencing (NGS) Market Analysis by key players

Next Generation Sequencing (NGS) Market, Next Generation Sequencing (NGS) Market Growth Trend, Next Generation Sequencing (NGS) Market Forecast, Next Generation Sequencing (NGS) Market Size Analysis, Next Generation Sequencing (NGS) Market Share, Next Generation Sequencing (NGS) Market Statistics

Next Generation Sequencing (NGS) Market Research Report is a professional and in-depth study on the current state of the global industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Next Generation Sequencing (NGS) Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1700726/?utm_source=openpr.com&utm_medium=RV

According to a new study, the global Next Generation Sequencing (NGS) market is anticipated to reach USD 16.6 billion by 2025. Next generation sequencing (NGS), is a DNA sequencing technology. The process of DNA sequencing, which decides the exact order of nucleotides inside a DNA molecule, is known as Next generation sequencing. Next generation sequencing is high throughput sequencing. Using next generation sequencer, the process produces a million DNA molecules and RNA sequences by allowing rapid nucleotide sequencing. Roche 454 sequencing and Illumina sequencing are the modern technologies of next generation sequencing. In comparison to Sanger?s sequencing method, the next generation sequencing is much cost-effective technique that provides better outcomes for DNA sequencing. An entire human genome can be sequenced in a single day using next generation sequencing, however, the Sanger sequencing technology, used to decode the human genome, required over a decade to bring the final summary.

By providing high flexibility, speed, throughput, and reduced sequencing cost, the introduction of next generation sequencing technologies has brought significant changes in sequencing technologies. In the single sequencing run, the next generation sequencing has ability to generate of nucleotide sequence data. The applications of next generation sequencing are in the field of cancer research, genetic disease research, personalized medicines, biological drug discovery, newborn sequencing metgenomics, and agriculture research etc. Moreover, non-coding RNA expression profiling, identification of binding sites on transcriptional factor, and re- sequencing of targets are some more applications of next generation sequencing.

The adoption of next generation sequencing is mounting for diagnosis of inherited genetic disorders, cancer, HLA typing and identification of infectious diseases as it allows scanning of targeted genome in very small time, and this is expected to propel the growth of global next generation sequencing market over the forecast period.

The global market for next generation sequencing is segmented by application, technology, products, end user, and region. By application, the global next generation sequencing market is categorized as, drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others. The drug discovery/personalized medicine segment is estimated to account major share in global next generation sequencing market by application in 2017. The increasing demand of next generation sequencing base test for infectious diseases and cancer, and rising focus on developing and providing next generation sequencing- based diagnostic tests are the major factors contributing towards the high market share of the segment in the global market. Moreover, the growing research and development activities globally are significantly contributing towards the growth of market.

By Technology, the global next generation sequencing market is further sub segmented into Whole Genome Sequencing, Targeted Re-Sequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. By technology, the targeted sequencing & Re-sequencing segment accounted major share in global next generation sequencing market. The targeted sequencing reduces the sequencing cost, and it is target specified and also requires smaller dataset. Moreover, increasing demand target specific genomic studies s expected to propel the growth of segment in the global next generation sequencing market.

By product, the global next generation sequencing market is further categorized into instruments, reagents & consumables, and services. By consumables, the global next generation sequencing market is further segmented into sample preparation consumables, and other consumables. The sample preparation sample includes quality control consumables, library preparation, DNA fragmentation, end repair, A-tailing, and size selection etc. On the basis of services, the global next generation market is segmented into data management services, and sequencing services. The sequencing services segment includes, Targeted Re-Sequencing, RNA Sequencing Chip-Seq, Methyl-Seq, De Novo Sequencing etc. where, the data management services includes, NGS storage, management, NGS data analysis software & workbenches, and NGS data analysis services.

On the basis of end user, the global next generation sequencing market is further segmented into healthcare institutions, pharmaceutical & biotechnology companies, research and academic centers, and others. By end user, the research and academics segment accounted major share in global next generation sequencing market. High application of next generation sequencing tools in research is the one of the key factors contributing towards the high market share of the segment. The hospitals and clinics segment is expected to register high CAGR over the forecast period owing to increasing collaboration between hospitals and biotech and pharmaceutical companies to develop advanced test kits for diagnosis of diseases.

Some of the key players operating in global next generation sequencing market are Thermo Fisher Scientific Inc., Illumina, Inc., Roche Holding AG, QIAGEN N. V., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., GATC Biotech AG, Perkin Elmer, Inc., Agilent Technologies, Inc., Macrogen, Inc. , and Eurofins Scientific among others.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1700726/?utm_source=openpr.com&utm_medium=RV


Table of Contents:

Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Next Generation Sequencing Market Insights
3.1. Next Generation Sequencing? Industry snapshot
3.2. Next Generation Sequencing -Ecosystem analysis
3.3. Next Generation Sequencing market dynamics
3.3.1. Next Generation Sequencing? Market Forces
3.3.1.1. Next Generation Sequencing Market driver analysis
3.3.1.2. Next Generation Sequencing Market restraint/challenges analysis
3.3.1.3. Next Generation Sequencing Market opportunity analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Next Generation Sequencing market PEST analysis, 2017
3.3.4. Value Chain Analysis
3.3.5. Next Generation Sequencing Industry trends
3.3.6. Prevalence of next generation sequencing
4. Next Generation Sequencing Market Size and Forecast by Application
4.1. Key findings
4.2. Drug Discovery/Personalized Medicine
4.2.1. Global market estimates and forecasts, 2017 ? 2025
4.3. Genetic Screening
4.3.1. Global market estimates and forecasts, 2017 ? 2025
4.4. Diagnostics/Infectious Diseases
4.4.1. Global market estimates and forecasts, 2017 ? 2025
4.5. Agricultural & Animal Research
4.5.1. Global market estimates and forecasts, 2017 ? 2025
4.6. Others
4.6.1. Global market estimates and forecasts, 2017 ? 2025
5. Next Generation Sequencing Market Size and Forecast by Technology
5.1. Key findings
5.2. Whole Genome Sequencing
5.2.1. Global market estimates and forecasts, 2017 ? 2025
5.3. Targeted Sequencing & Re-sequencing
5.3.1. Global market estimates and forecasts, 2017 ? 2025
5.4. Whole Exome Sequencing
5.4.1. Global market estimates and forecasts, 2017 ? 2025
5.5. RNA Sequencing
5.5.1. Global market estimates and forecasts, 2017 ? 2025
5.6. Chip Sequencing
5.6.1. Global market estimates and forecasts, 2017 ? 2025
5.7. De Novo Sequencing
5.7.1. Global market estimates and forecasts, 2017 ? 2025
5.8. Methyl Sequencing
5.8.1. Global market estimates and forecasts, 2017 ? 2025
6. Next Generation Sequencing Market Size and Forecast by Products
6.1. Key findings
6.2. Instruments
6.2.1. Global market estimates and forecasts, 2017 ? 2025
6.3. Reagents & Consumables
6.3.1. Global market estimates and forecasts, 2017 ? 2025
6.3.2. Next Generation Sequencing Market by sample preparation consumables (USD Million), 2017 ? 2025
6.3.3. Next Generation Sequencing Market by Others (USD Million), 2017 ? 2025
6.4. Services
6.4.1. Global market estimates and forecasts, 2017 ? 2025
6.4.2. Next Generation Sequencing Market by Data Management Services (USD Million), 2017 ? 2025
6.4.3. Next Generation Sequencing Market by Sequencing Services (USD Million), 2017 ? 2025
7. Next Generation Sequencing Market Size and Forecast by End User
7.1. Key findings
7.2. Healthcare Institutions

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Sequencing (NGS) Market Analysis by key players Thermo Fisher Scientific Inc., Illumina, Inc., Roche Holding AG QIAGEN N. V., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., GA here

News-ID: 1768550 • Views: 896

More Releases from marketstudyreport

Medical Automation Technologies Market Analysis by Top Manufacturers, Shares, Gr …
Market Study Report, LLC's latest research report on Medical Automation Technologies Market, delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, Medical Automation Technologies market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business. Request a sample Report of Medical Automation Technologies Market at: https://www.marketstudyreport.com/request-a-sample/1524757?utm_source=openpr.com&utm_medium=PC Medical automation technologies is an independent of efficient, effective and equitable
What's driving the Automotive Diagnostic Scan Tools Market trends? Key Players a …
MarketStudyReport.com Adds New Report Automotive Diagnostic Scan Tools Market 2019 - 2025 research report providing information and data By Offering, Diagnostic Software, Diagnostic Services, By Application, By Tool Type, Industry Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast spreading across 320 Pages with table and figures in it. Europe is anticipated to be the prominent region in the automotive diagnostic scan tools market with the market share of over
Comprehensive analysis on Endpoint Security Market| Key Players are F-Secure, We …
MarketStudyReport.com Adds New Endpoint Security Market 2017 - 2024 research report providing information and data By Component, By Service, By Application, Industry Analysis, Regional Outlook, Growth Potential, Trends, By Deployment Model, Competitive Market Share & Forecast spreading across 380 Pages with table and figures in it. North America dominated the endpoint protection market in 2016 and is projected to maintain the dominance throughout the forecast period, primarily due to large-scale deployment
Veterinary Vaccines Market is Booming 2019 | By Players include Zoetis Inc. Merc …
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1513665/?utm_source=Openpr&utm_medium=RV The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products

All 5 Releases


More Releases for Sequencing

Next Generation Sequencing Market
According to IMARC Group’s latest report, titled “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global next generation sequencing (NGS) market is expanding at double digit growth rate and is expected to grow at a CAGR of 17% during 2020-2025. Next-generation sequencing refers to the process of determining the sequence of nucleotides in DNA. It involves various procedures, such as sequencing by synthesis (SBS),
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Next-generation Sequencing Market
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate,